Leading traditional therapy drugs in the U.S. by percent of total spending 2016

This statistic shows the leading traditional therapeutic drugs in the United States in 2016, based on percentage of total traditional spending. The drug Lantus (insulin glargine) for diabetes had the highest percent of total traditional spending, reaching 2.4 percent in that year.

Top 10 traditional therapy drugs in the U.S. by share of total traditional spending in 2016*

Percentage of total traditional spending
Lantus (insulin glargine)2.4%
Humalog (insulin lispro injection)1.7%
Metformin1.6%
Vyvanse (lisdexamfetamine)1.5%
Lialda (mesalamine)1.3%
Januvia (sitagliptin)1.3%
Esomeprazole magnesium1.3%
Methylphenidate extended release1.2%
Amphetamine/dextroamphetamine1.2%
Lyrica (pregabalin)1.2%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2017

Region

United States

Survey time period

2016

Supplementary notes

* The statistic includes members with commercial insurance coverage. Members used Express Scripts for retail and home delivery pharmacy services; they used Accredo, the Express Scripts specialty pharmacy, for specialty drug prescriptions.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.